- Home
- PDS vs CDNA Comparison
PDS vs CDNA Comparison
Compare PDS & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDS
- CDNA
- Stock Information
- Founded
- PDS 1951
- CDNA 1998
- Country
- PDS Canada
- CDNA United States
- Employees
- PDS N/A
- CDNA N/A
- Industry
- PDS
- CDNA Medical Specialities
- Sector
- PDS
- CDNA Health Care
- Exchange
- PDS Nasdaq
- CDNA Nasdaq
- Market Cap
- PDS 720.5M
- CDNA 712.2M
- IPO Year
- PDS N/A
- CDNA 2014
- Fundamental
- Price
- PDS $53.97
- CDNA $11.84
- Analyst Decision
- PDS Buy
- CDNA Buy
- Analyst Count
- PDS 2
- CDNA 6
- Target Price
- PDS $87.00
- CDNA $27.67
- AVG Volume (30 Days)
- PDS 88.5K
- CDNA 1.5M
- Earning Date
- PDS 07-29-2025
- CDNA 08-06-2025
- Dividend Yield
- PDS N/A
- CDNA N/A
- EPS Growth
- PDS N/A
- CDNA N/A
- EPS
- PDS 5.22
- CDNA 1.00
- Revenue
- PDS $1,355,177,217.00
- CDNA $340,826,000.00
- Revenue This Year
- PDS $0.98
- CDNA $12.81
- Revenue Next Year
- PDS $1.30
- CDNA $13.36
- P/E Ratio
- PDS $10.35
- CDNA $11.85
- Revenue Growth
- PDS N/A
- CDNA 14.72
- 52 Week Low
- PDS $36.20
- CDNA $10.96
- 52 Week High
- PDS $75.19
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- PDS 53.56
- CDNA 33.98
- Support Level
- PDS $54.17
- CDNA $11.73
- Resistance Level
- PDS $56.44
- CDNA $12.76
- Average True Range (ATR)
- PDS 1.70
- CDNA 0.64
- MACD
- PDS -0.16
- CDNA 0.13
- Stochastic Oscillator
- PDS 38.61
- CDNA 28.61
About PDS Precision Drilling Corporation
Precision Drilling Corp is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.